Final answer:
Swiss type agammaglobulinemia is an X-linked immunodeficiency affecting B cell development, resulting in the absence of specific antibody production and recurrent infections.
Step-by-step explanation:
Swiss type agammaglobulinemia, also known as X-linked agammaglobulinemia (XLA), is an X-linked immunodeficiency affecting B cell development. This condition is characterized by the absence of immunoglobulin in the serum due to defective differentiation, leading to a lack of specific antibody production. The defective gene responsible for XLA encodes for Bruton tyrosine kinase (Btk), which is vital for B-cell maturation and differentiation beyond the pre-B-cell stage, which is required for producing antibodies.
Consequently, patients with XLA suffer from recurrent infections primarily due to extracellular pathogens.